Benitec Biopharma Inc. (NASDAQ: BNTC), a prominent player in the biotechnology sector, is capturing investor attention with a remarkable potential upside of 120.30%. As a clinical-stage company headquartering in Hayward,..
Dayforce, Inc. (NASDAQ: DAY), a prominent player in the technology sector, has been making waves in the software application industry, primarily through its comprehensive human capital management (HCM) solutions. As..
Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is drawing attention from investors with its significant potential upside and a diverse pipeline aimed at addressing high unmet medical needs. Operating within the biotechnology..
Materialise NV (MTLS), a prominent player in the technology sector, is a Belgium-based company that has carved its niche in the realm of application software. With a market capitalization of..
Immutep Limited (NASDAQ: IMMP), an Australian biotechnology firm, is making waves in the healthcare sector with its innovative approach to immunotherapy. Specializing in Lymphocyte Activation Gene-3 (LAG-3) related treatments for..
AMTD Digital Inc. (NYSE: HKD) has captured investor attention with its impressive revenue growth, despite the absence of traditional valuation metrics. As a player in the Technology sector, specifically the..
Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) stands out in the biotechnology sector with its innovative approach to developing mRNA medicines, focusing on therapeutics for liver and respiratory rare diseases. As..
For individual investors keeping an eye on the healthcare sector, Nyxoah SA (NASDAQ: NYXH) presents an intriguing opportunity within the medical instruments and supplies industry. Headquartered in Mont-Saint-Guibert, Belgium, Nyxoah..
UroGen Pharma Ltd. (NASDAQ: URGN), a burgeoning player in the biotechnology sector, is captivating investor interest with its promising portfolio in urothelial and specialty cancer solutions. Headquartered in Princeton, New..
Porch Group, Inc. (NASDAQ: PRCH) is capturing investor attention with a staggering potential upside of 123.7%, based on current analyst ratings. As a company operating at the intersection of technology..
aTyr Pharma, Inc. (ATYR), a clinical-stage biotechnology company, is gaining significant attention in the investment community, particularly due to its intriguing upside potential. With a market capitalization of $83.42 million,..
Abeona Therapeutics Inc. (NASDAQ: ABEO) is capturing the attention of investors with its promising position in the biotechnology sector, particularly highlighted by a potential upside of 327.32%. This United States-based..
For investors seeking opportunities in the healthcare sector, Neuronetics, Inc. (NASDAQ: STIM) presents a compelling case with its innovative approach to treating neurohealth disorders. Specializing in medical devices, Neuronetics is..
For investors seeking opportunities in the biotechnology sector, Palvella Therapeutics, Inc. (PVLA) offers a compelling case with its sharp focus on rare genetic skin diseases. With an impressive market cap..
SoundHound AI, Inc. (NASDAQ: SOUN), an innovative player in the technology sector specializing in voice artificial intelligence solutions, has captured the attention of many investors with its remarkable potential upside..
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is capturing the attention of investors with its impressive potential upside of 112.75%. As a biopharmaceutical company focused on developing innovative treatments for gastrointestinal diseases,..
Fulcrum Therapeutics, Inc. (NASDAQ: FULC), a clinical-stage biopharmaceutical company, stands at the intersection of innovation and potential in the healthcare sector. Focused on developing small molecules for genetically defined diseases,..
In the ever-evolving landscape of biotechnology, Alumis Inc. (ALMS) stands out as a dynamic player with promising potential for significant growth. Headquartered in South San Francisco, this clinical-stage biopharmaceutical company..
Alpha Tau Medical Ltd. (NASDAQ: DRTS) stands as a promising player in the biotechnology sector, headquartered in Jerusalem, Israel. Specializing in oncology therapeutics, the company focuses on the development and..
XOMA Royalty Corporation (NASDAQ: XOMA), a pioneering entity in the biotechnology sector, is catching the eye of investors with its remarkable potential upside of 98.76%, as suggested by recent analyst..
